Topic
Neeraj Sharma
News
5 May 2026
OneSource Supports Second Generic Semaglutide Approval in Canada
OneSource Specialty Pharma Limited (BSE: 544292, NSE: ONESOURCE) has announced that its partner Orbicular, along with its Canadian front-end partner,…
News
5 Mar 2025
OneSource Specialty Pharma appoints three independent directors
The directors bring decades of leadership experience and expertise in Pharma, Business Strategy, Transformation, Merger & Acquisition (M&A) among others…
Corporate
30 Jan 2025
OneSource receives EIR for Bengaluru facility
The report follows a comprehensive inspection of the facility, conducted from November 14 to November 22, 2024 OneSource Specialty Pharma…